Company intelligence / Profile preview

Unisensor

Liège, Liège Province, Belgiumunisensor.be ↗

Ownership: Private
Development stage: Commercial

Overview

Unisensor develops and commercializes rapid screening solutions for detecting antibiotics, mycotoxins, and contaminants in dairy products, cereals, honey, animal feed, meat and seafood. Their multiplexing technology enables simultaneous detection of multiple analytes. The company has a global presence with distribution in over 60 countries.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceDiagnostic kitReagent
Industry: Metabolite Diagnostics

Partnerships

Extensive network of local distributors (>60 countries)

Beyond the preview

Go deeper on Unisensor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unisensor.

Explore the full profile